Publication: 979

Publication: 979

CALGB 50803 (Alliance): A phase 2 trial of lenalidomide plus rituximab in patients with previously untreated follicular lymphoma

URL

Google Scholar

Citation:: Hematol Oncol vol 31 (suppl 1) abstr 063

Meeting Instance:: ICML 2013
Year:: 2013
Type:: Abstract
Sub type:: Poster General
Funding:: NCTN
Endpoint:: Primary
Analysis:: Preliminary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: ppub

Note:

Methodological:: No
Biospecimen:: No
SDC:: No

Parents:: None
Children:: 2762

Program:: OGC
Primary Committee:: Lymphoma
Sec. Committees:

Pharmas:
Grants:

Corr. Author:
Authors:: P. Martin S.-H. Jung J. Johnson R. Elstrom N. L. Bartlett K. Blum T. Shea J. Leonard B. Cheson

Networks:

Study: CALGB-50803
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 2

Keywords: